{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T05:31:58Z","timestamp":1738042318937,"version":"3.33.0"},"reference-count":38,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Cardiol Young"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>As the life expectancy improves in cystic fibrosis, cardiac dysfunction is becoming an important risk factor for morbidity and mortality. Here, the association of cardiac dysfunction with proinflammatory markers and neurohormones between cystic fibrosis patients and healthy children was investigated. Echocardiographic measurements of right and left ventricular morphology and functions together with levels of proinflammatory markers and neurohormones (renin, angiotensin-II, and aldosterone) were obtained and analysed in a study group of 21 cystic fibrosis children aged 5\u201318 years and compared with age- and gender-matched healthy children. It was shown that patients had significantly higher interleukin-6, C-reactive protein, renin and aldosterone levels (<jats:italic>p<\/jats:italic> &lt; 0.05), dilated right ventricles, decreased left ventricle sizes, as well as both right and left ventricular dysfunction. These echocardiographic changes correlated with hypoxia, interleukin-1 \u03b1, interleukin-6, C-reactive protein, and aldosterone (p &lt; 0.05) levels. The current study revealed that hypoxia, proinflammatory markers, and neurohormones are major determinants of subclinical changes in ventricular morphology and function. While the right ventricle anatomy was affected by cardiac remodeling, the left ventricle changes were induced by right ventricle dilation and hypoxia. A significant but subclinical systolic and diastolic right ventricle dysfunction in our patients was associated with hypoxia and inflammatory markers. Systolic left ventricle function was affected by hypoxia and neurohormones. Echocardiography is a reliable and non-invasive method that is used safely in cystic fibrosis children for screening and detection of cardiac anatomical and functional changes. Extensive studies are needed to determine the time and frequency of screening and treatment suggestions for such changes.<\/jats:p>","DOI":"10.1017\/s1047951123001178","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T09:35:45Z","timestamp":1684488945000},"page":"73-78","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Proinflammatory indicators and the relevance of echocardiography in children with cystic fibrosis"],"prefix":"10.1017","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8244-1226","authenticated-orcid":false,"given":"Ovgu Ozenli","family":"Yagci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6384-3935","authenticated-orcid":false,"given":"Ay\u015fe","family":"Sulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3926-9002","authenticated-orcid":false,"given":"Pelin","family":"Kosger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonca Kilic","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hulya","family":"Anil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birsen","family":"Ucar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koray","family":"Harmanci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"S1047951123001178_ref2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-0035-1547347","article-title":"Lung transplantation for cystic fibrosis: results, indications, complications, and controversies","volume":"36","author":"Lynch","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"S1047951123001178_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2010.03.019"},{"key":"S1047951123001178_ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000098480"},{"key":"S1047951123001178_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2003.10.010"},{"key":"S1047951123001178_ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)30107-2"},{"key":"S1047951123001178_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2012.03.002"},{"key":"S1047951123001178_ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200109000-00017"},{"key":"S1047951123001178_ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-012-0407-4"},{"key":"S1047951123001178_ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.597675"},{"key":"S1047951123001178_ref27","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e3283659e9f"},{"key":"S1047951123001178_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2011.06.004"},{"key":"S1047951123001178_ref17","doi-asserted-by":"publisher","DOI":"10.1042\/cs0850563"},{"key":"S1047951123001178_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2006.03.011"},{"key":"S1047951123001178_ref25","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.6.9704086"},{"key":"S1047951123001178_ref6","first-page":"10205","article-title":"Cardiac involvement in mild cystic fibrosis lung involvement assessed by Tissue-Doppler echocardiography","volume":"7","author":"Ghaderian","year":"2019","journal-title":"Int J Pediatr."},{"key":"S1047951123001178_ref8","doi-asserted-by":"publisher","DOI":"10.1111\/echo.14860"},{"key":"S1047951123001178_ref29","first-page":"e16723","article-title":"Cardiovascular system involvement in cystic fibrosis","volume":"13","author":"Shah","year":"2021","journal-title":"Cureus"},{"key":"S1047951123001178_ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2015.03.006"},{"key":"S1047951123001178_ref32","doi-asserted-by":"publisher","DOI":"10.1378\/chest.80.4.399"},{"key":"S1047951123001178_ref34","unstructured":"34. Bornstein, AB , Rao, SS , Marwaha, KL. Left ventricular hypertrophy. StatPearls publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557534\/. Accessed 23 December 2021."},{"key":"S1047951123001178_ref35","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009708"},{"key":"S1047951123001178_ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2004.06.006"},{"key":"S1047951123001178_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(80)80256-3"},{"key":"S1047951123001178_ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00079"},{"key":"S1047951123001178_ref18","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1934"},{"key":"S1047951123001178_ref20","doi-asserted-by":"publisher","DOI":"10.1111\/echo.14793"},{"key":"S1047951123001178_ref26","article-title":"Pulmonary hypertension and pulmonary disorders in cystic fibrosis","volume":"4","author":"Rovedder","year":"2014","journal-title":"Cardiovasc pharmacol open acc Los Angeles"},{"key":"S1047951123001178_ref9","first-page":"2","article-title":"The heart in cystic fibrosis","volume":"41","author":"Bright-Thomas","year":"2002","journal-title":"J R Soc Med."},{"key":"S1047951123001178_ref36","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/16.suppl_O.107"},{"key":"S1047951123001178_ref31","doi-asserted-by":"publisher","DOI":"10.1111\/echo.12541"},{"key":"S1047951123001178_ref38","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.158915"},{"key":"S1047951123001178_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.08.028"},{"key":"S1047951123001178_ref14","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.5.9908005"},{"key":"S1047951123001178_ref19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081141"},{"key":"S1047951123001178_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2017.12.009"},{"key":"S1047951123001178_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2006.12.010"},{"key":"S1047951123001178_ref37","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/61.suppl_2.S4"},{"key":"S1047951123001178_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.08.013"}],"container-title":["Cardiology in the Young"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1047951123001178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T12:49:32Z","timestamp":1737982172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1047951123001178\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1047951123001178"],"URL":"https:\/\/doi.org\/10.1017\/s1047951123001178","relation":{},"ISSN":["1047-9511","1467-1107"],"issn-type":[{"type":"print","value":"1047-9511"},{"type":"electronic","value":"1467-1107"}],"subject":[],"published":{"date-parts":[[2023,5,19]]},"assertion":[{"value":"\u00a9 The Author(s), 2023. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}